Q13627 (DYR1A_HUMAN) Homo sapiens (Human)

Dual specificity tyrosine-phosphorylation-regulated kinase 1A UniProtKBInterProSTRINGInteractive Modelling

763 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5); 9 identical sequences: Equus caballus: A0A3Q2I3Y0; Equus asinus: A0A9L0K5Y6; Pongo abelii: A0A2J8UAI1; Pan troglodytes: H2QL08, A0A6D2WLE2; Camelus ferus: A0A8B8RZL9; Microcebus murinus: A0A8C5VDN6; Vicugna pacos: A0A6I9I9S6; Pteropus vampyrus: A0A6P3QPJ4

Available Structures

83 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human Dual-Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A in complex with a consensus sub… Heteromer
Q5IJ48;
136-480
100.0D15;CL;
Crystal structure of DYRK1A in complex with AZ191homo-4-mer134-480
100.0QS0; 32×EDO;SO4;
Crystal structure of human DYRK1A in complex with compound 14monomer134-483
100.0SO4;9OF;PGE;
Human DYRK1A in complex with Leucettine L41monomer132-481
1003RA;
Crystal Structure of DYRK1A with small molecule inhibitormonomer134-482
100.0SO4;EDO;KQK;
Crystal structure of DYRK1A complexed with FC162 inhibitormonomer134-482
100SO4;PG4;DMS;JHW;
Crystal structure of DYRK1A with harmine-derivatized AnnH-75 inhibitormonomer134-482
100PG4;4H5;
DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.monomer131-479
100.0Q8J;
Crystal structure of DYRK1A in complex with 10-Chloro-substituted 11H-indolo[3,2-c]quinolone-6-carb…monomer134-481
100.0SO4; 12×EDO;4E2;IOD;
Crystal structure of DYRK1AA in complex with 10-Bromo-substituted 11H-indolo[3,2-c]quinolone-6-carb…monomer134-481
100.0SO4;EDO;4E3;
DYRK1A in complex with hydroxy benzothiazole fragmentmonomer134-481
100.0QIV;
DYRK1a in Complex with a Bromo-Triazolo-Pyridinemonomer135-482
100IWU;PG4;PEG;PGE;GOL;EPE;1PE;SO4;CL;
Crystal structure of DYRK1A in complex with RD0392monomer134-481
100.04VZ;GOL;
human DYRK1A/harmine complexmonomer134-481
100.0HRM;
human DYRK1A/inhibitor complexmonomer134-481
100.0EHB;
Crystal structure of DYRK1A in complex with RD0448monomer134-481
100.04WD;
Human DYRK1A in complex with LDN-211898monomer134-481
100.0AWR;PO4;
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-481
100.0SO4;KQW;
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-481
100.0SO4;KRQ;EDO;
Crystal Structure of DYRK1A with small molecule inhibitormonomer134-480
100.0KRK;EDO;DMS;SO4;
Crystal structure of the human DYRK1A kinase domain bound to abemaciclibmonomer134-480
100.0FLC;6ZV;EDO;PEG;LI;
Crystal structure of human DYRK1A in complex with compound 32monomer134-480
100.09OL;
DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENTmonomer134-480
100.0AJG;
DYRK1A in complex with XMD7-117monomer134-480
100.0B5T;
DYRK1a in Complex with 2-Cyclopentyl-7-iodo-1H-indole-3-carbonitrilemonomer135-481
100YOX;1PE;PG4;EPE;PEG;GOL;EDO;SO4;
DYRK1A in complex with XMD14-124monomer134-480
100.0B6Z;
Crystal structure of DYRK1A in complex with rutinmonomer134-480
100.0RUT;
DYRK1A in complex with JWC-055monomer134-480
100.0B6N;
DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENTmonomer134-480
100.0Y3L;
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-481
100SO4;PG4;KR8;
Crystal structure of human DYRK1A in complex with ARN25068monomer135-481
100.039I;
Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1Amonomer135-481
100D15;CL;P6G;SO4;
DYRK1A in complex with XMD15-27-2monomer134-480
100.0B6H;
DYRK1A in complex with HG-8-60-1monomer134-480
100.0B5Z;
Crystal Structure of DYRK1A with small molecule inhibitormonomer134-480
100.0CL;KQE;
DYRK1A in complex with XMD8-49monomer134-480
100.0B6B;
DYRK1A in complex with XMD8-62emonomer134-480
100.0B7B;
Crystal structure of DYRK1A in complex with 10-Iodo-substituted 11H-indolo[3,2-c]quinoline-6-carbox…monomer135-481
100PG4;SO4;4E1;
Human DYRK1A in complex with PKC412monomer134-480
100.02K2;
DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENTmonomer134-480
100.05PW;
DYRK1A in complex with methoxy benzothiazole fragmentmonomer134-480
100.07QQ;
DYRK1A in complex with JWD-065monomer134-480
100.0B6Q;
DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENTmonomer134-480
100.0ZC3;
Crystal structure of DYRK1A complexed with KuFal319 (compound 11)monomer135-481
100PG4;SO4;MLW;
DYRK1A in complex with XMD7-112monomer134-480
100.0B7W;
DYRK1A bound to a harmine derivativemonomer135-481
100QKG;PG4;
DYRK1A with PST001monomer134-480
100.0OPW;
Crystal Structure of DYRK1A with small molecule inhibitormonomer135-480
100.0SO4;KQZ;EDO;
Structure of DYRK1A in complex with AMPNPmonomer136-481
100.0ANP;
Crystal structure of DYRK1A in complex with gossypinmonomer135-480
100R7O;ACT;
Structure of DYRK1A in complex with compound 8monomer136-481
100.0QZ2;
The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitormonomer135-480
1002C3;1PE;SO4;
Structure of DYRK1A in complex with complex 10monomer136-481
100.0MFR;
A natural inhibitor of DYRK1A for treatment of diabetes mellitusmonomer135-480
100.0EKU;
Structure of DYRK1A in complex with compound 3monomer136-481
100.0QYH;
Crystal structure of DYRK1A in complex with CX-4945monomer135-480
1003NG;SO4;PG4;PEG;EDO;
The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitormonomer136-481
100.02C4;1PE;SO4;
DYRK1A complex with DYR530monomer136-480
100.0XIR;PG4;GOL;
Structure of DYRK1A in complex with compound 16monomer148-481
100.0CL;QYW;
Structure of DYRK1A in complex with compound 4monomer148-481
100.06SD;
Structure of DYRK1A in complex with compound 54monomer148-481
100.0RK2;DMS;
Structure of DYRK1A in complex with compound 5monomer148-481
100.0QYK;
Structure of DYRK1A in complex with compound 50monomer148-481
100.0RK5;CL;
Structure of DYRK1A in complex with compound 25monomer148-481
100.0RJ8;CL;
Structure of DYRK1A in complex with compound 3monomer148-481
100.0RJ5;CL;
Structure of DYRK1A in complex with compound 53monomer148-481
100.0RHH;PO4;DMS;
Structure of DYRK1A in complex with compound 38monomer148-481
100.0RKK;CL;
tructure of DYRK1A in complex with compound 24monomer148-481
100.0QZW;CL;
Structure of DYRK1A in complex with compound 28monomer148-481
100.0RJ2;CL;
Structure of DYRK1A in complex with compound 7monomer148-481
100.0QYZ;
Structure of DYRK1A in complex with compound 51monomer148-481
100.0RKZ;CL;
Structure of DYRK1A in complex with compound 34monomer148-481
100.0R05;CL;
Structure of DYRK1A in complex with compound 58monomer148-481
100.0RK8;
Structure of DYRK1A in complex with compound 56monomer148-481
100.0RJZ;
Structure of DYRK1A in complex with compound 5monomer149-481
100.0RHZ;CL;
Structure of DYRK1A in complex with compound 10monomer149-481
100.0RHW;CL;
Structure of DYRK1A in complex with compound 46monomer149-481
100.0RKQ;CL;
Structure of DYRK1A in complex with compound 16monomer149-481
100.0RHT;CL;
Structure of DYRK1A in complex with compound 2monomer149-481
100.0QYE;
Structure of DYRK1A in complex with compound 1monomer148-479
100.0QY8;DMS;
Structure of DYRK1A in complex with compound 6monomer148-479
100.0QYB;PO4;
Structure of DYRK1A in complex with compound 33monomer148-479
100.0RKH;GOL;
Structure of DYRK1A in complex with compound 32monomer148-479
100.0RKW;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3anr.1.Amonomer0.83134-481
HRM;100.00
7lgs.4.Amonomer0.50149-456
16.83

8 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23anr.1.Amonomer0.83125-472
HRM;100.00
Isoform 27lgs.4.Amonomer0.50140-447
16.83
Isoform 34nct.1.Amonomer0.85134-480
2K2;100.00
Isoform 37lgs.4.Amonomer0.51150-456
16.83
Isoform 44nct.1.Amonomer0.86134-480
2K2;100.00
Isoform 47lgs.4.Amonomer0.51150-456
16.83
Isoform 53anr.1.Amonomer0.85134-481
HRM;100.00
Isoform 57lgs.4.Amonomer0.50150-456
16.78